Stock listing
NSE:DRREDDY Dr. Reddy's Laboratories Ltd. Share Price
Home listing (NSE) of Dr. Reddy's Laboratories Ltd.
Follow Dr. Reddy's Laboratories Ltd. into a list and get an email when it puts out news.
Share price · NSE:DRREDDY
₹1,390.20 INR -8.00 (-0.6%)
Close on Nov 20, 2026
- Day range
- ₹1,384.80 – ₹1,400.00 INRNov 20, 2026
- Volume
- 830,660 sharesNov 20, 2026
- Market cap
- ₹1.16T INRAt the close on Nov 20, 2026 · price × 833.1M shares outstanding
- 52-week range
- ₹1,101.00 – ₹1,414.90 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹2.32B INRMedian day 1.68M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:DRREDDY · Home | ₹1,390.20 INR | -8.00 (-0.6%) | 830,660 | ₹1,388.00 | ₹1,400.00 | ₹1,384.80 | ₹1,398.20 | Close on Nov 20, 2026 |
| NYSE:RDY | $14.89 USD | +0.06 (+0.4%) | 1,706,216 | $14.88 | $15.10 | $14.86 | $14.83 | Close on Nov 20, 2026 |
| Frankfurt:RDDA | €13.30 EUR | -0.20 (-1.5%) | — | €13.30 | €13.30 | €13.30 | €13.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:DRREDDY · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹1,390.20 | -8.00 | -0.6% | ₹1,388.00 | ₹1,400.00 | ₹1,384.80 | 830,660 | |
| ₹1,398.20 | +10.20 | +0.7% | ₹1,383.70 | ₹1,406.10 | ₹1,376.40 | 1,270,957 | |
| ₹1,388.00 | +10.10 | +0.7% | ₹1,377.00 | ₹1,388.90 | ₹1,368.70 | 964,023 | |
| ₹1,377.90 | -2.10 | -0.2% | ₹1,383.00 | ₹1,395.00 | ₹1,372.30 | 974,997 | |
| ₹1,380.00 | -6.60 | -0.5% | ₹1,380.00 | ₹1,404.00 | ₹1,375.80 | 1,308,089 | |
| ₹1,386.60 | +9.60 | +0.7% | ₹1,377.00 | ₹1,389.80 | ₹1,371.90 | 1,222,604 | |
| ₹1,377.00 | -8.00 | -0.6% | ₹1,399.00 | ₹1,399.00 | ₹1,372.40 | 1,687,351 | |
| ₹1,385.00 | +12.00 | +0.9% | ₹1,375.00 | ₹1,390.30 | ₹1,369.30 | 1,788,177 | |
| ₹1,373.00 | +7.00 | +0.5% | ₹1,358.40 | ₹1,373.00 | ₹1,358.40 | 1,343,395 | |
| ₹1,366.00 | -8.00 | -0.6% | ₹1,377.00 | ₹1,384.00 | ₹1,357.00 | 1,841,384 | |
| ₹1,374.00 | +5.70 | +0.4% | ₹1,360.00 | ₹1,376.70 | ₹1,359.80 | 1,828,860 | |
| ₹1,368.30 | +26.30 | +2.0% | ₹1,355.00 | ₹1,368.30 | ₹1,338.50 | 1,956,253 | |
| ₹1,342.00 | -10.00 | -0.7% | ₹1,352.00 | ₹1,364.90 | ₹1,336.70 | 2,054,116 | |
| ₹1,352.00 | +7.00 | +0.5% | ₹1,345.00 | ₹1,363.70 | ₹1,345.00 | 1,714,059 | |
| ₹1,345.00 | +9.60 | +0.7% | ₹1,343.50 | ₹1,352.80 | ₹1,336.10 | 2,020,772 | |
| ₹1,335.40 | +25.40 | +1.9% | ₹1,302.00 | ₹1,338.20 | ₹1,301.00 | 2,839,063 | |
| ₹1,310.00 | -0.90 | -0.1% | ₹1,309.00 | ₹1,323.70 | ₹1,299.40 | 2,201,002 | |
| ₹1,310.90 | +81.40 | +6.6% | ₹1,260.00 | ₹1,319.00 | ₹1,224.00 | 10,003,270 | |
| ₹1,229.50 | -9.50 | -0.8% | ₹1,236.20 | ₹1,250.60 | ₹1,215.60 | 1,550,206 | |
| ₹1,239.00 | -5.50 | -0.4% | ₹1,236.00 | ₹1,250.70 | ₹1,212.70 | 2,805,310 | |
| ₹1,244.50 | +2.00 | +0.2% | ₹1,245.00 | ₹1,252.00 | ₹1,232.50 | 1,223,759 | |
| ₹1,242.50 | +9.50 | +0.8% | ₹1,232.00 | ₹1,245.00 | ₹1,227.00 | 1,023,837 | |
| ₹1,233.00 | +14.20 | +1.2% | ₹1,222.00 | ₹1,233.00 | ₹1,214.10 | 1,261,028 | |
| ₹1,218.80 | +2.80 | +0.2% | ₹1,211.10 | ₹1,234.20 | ₹1,206.60 | 1,392,873 | |
| ₹1,216.00 | -24.00 | -1.9% | ₹1,234.20 | ₹1,234.40 | ₹1,209.60 | 1,615,685 | |
| ₹1,240.00 | +10.60 | +0.9% | ₹1,230.90 | ₹1,250.70 | ₹1,223.30 | 2,417,763 | |
| ₹1,229.40 | +32.40 | +2.7% | ₹1,197.00 | ₹1,235.00 | ₹1,196.90 | 1,756,682 | |
| ₹1,197.00 | +17.00 | +1.4% | ₹1,180.00 | ₹1,200.80 | ₹1,172.00 | 1,510,336 | |
| ₹1,180.00 | -23.80 | -2.0% | ₹1,197.30 | ₹1,201.20 | ₹1,167.20 | 2,278,637 | |
| ₹1,203.80 | -4.20 | -0.3% | ₹1,208.00 | ₹1,222.80 | ₹1,192.20 | 1,754,646 | |
| ₹1,208.00 | +5.00 | +0.4% | ₹1,207.00 | ₹1,212.70 | ₹1,195.00 | 1,638,100 | |
| ₹1,203.00 | -3.20 | -0.3% | ₹1,198.00 | ₹1,206.60 | ₹1,189.00 | 3,075,974 | |
| ₹1,206.20 | -26.80 | -2.2% | ₹1,233.00 | ₹1,233.90 | ₹1,194.90 | 2,607,818 | |
| ₹1,233.00 | -18.90 | -1.5% | ₹1,242.20 | ₹1,244.60 | ₹1,214.20 | 4,026,022 | |
| ₹1,251.90 | +30.90 | +2.5% | ₹1,243.20 | ₹1,252.80 | ₹1,229.00 | 5,347,128 | |
| ₹1,221.00 | +20.00 | +1.7% | ₹1,211.60 | ₹1,229.80 | ₹1,204.00 | 3,401,676 | |
| ₹1,201.00 | +0.60 | 0.0% | ₹1,204.50 | ₹1,207.80 | ₹1,193.40 | 1,001,238 | |
| ₹1,200.40 | -10.80 | -0.9% | ₹1,210.90 | ₹1,213.90 | ₹1,197.00 | 1,667,696 | |
| ₹1,211.20 | +0.20 | 0.0% | ₹1,210.00 | ₹1,220.50 | ₹1,205.90 | 987,420 | |
| ₹1,211.00 | +12.70 | +1.1% | ₹1,207.00 | ₹1,222.00 | ₹1,201.20 | 3,355,097 | |
| ₹1,198.30 | +13.30 | +1.1% | ₹1,185.00 | ₹1,211.90 | ₹1,185.00 | 1,718,834 | |
| ₹1,185.00 | +10.00 | +0.9% | ₹1,182.60 | ₹1,207.50 | ₹1,182.10 | 3,002,566 | |
| ₹1,175.00 | +35.00 | +3.1% | ₹1,140.00 | ₹1,189.80 | ₹1,140.00 | 2,311,932 | |
| ₹1,140.00 | -5.00 | -0.4% | ₹1,142.00 | ₹1,149.90 | ₹1,133.90 | 1,120,896 | |
| ₹1,145.00 | -20.50 | -1.8% | ₹1,163.70 | ₹1,168.50 | ₹1,141.00 | 1,810,974 | |
| ₹1,165.50 | +22.50 | +2.0% | ₹1,130.00 | ₹1,182.00 | ₹1,130.00 | 2,403,285 | |
| ₹1,143.00 | -2.00 | -0.2% | ₹1,140.00 | ₹1,147.20 | ₹1,134.90 | 1,684,792 | |
| ₹1,145.00 | -6.00 | -0.5% | ₹1,146.00 | ₹1,151.00 | ₹1,136.40 | 528,499 | |
| ₹1,151.00 | +6.80 | +0.6% | ₹1,146.50 | ₹1,154.50 | ₹1,144.00 | 587,270 | |
| ₹1,144.20 | -6.80 | -0.6% | ₹1,150.50 | ₹1,163.20 | ₹1,141.80 | 420,952 | |
| ₹1,151.00 | -4.00 | -0.3% | ₹1,157.00 | ₹1,166.80 | ₹1,151.00 | 568,461 | |
| ₹1,155.00 | -1.50 | -0.1% | ₹1,162.00 | ₹1,164.30 | ₹1,155.00 | 338,274 | |
| ₹1,156.50 | -14.50 | -1.2% | ₹1,165.00 | ₹1,170.90 | ₹1,156.50 | 486,542 | |
| ₹1,171.00 | +16.60 | +1.4% | ₹1,166.50 | ₹1,179.90 | ₹1,166.50 | 556,259 | |
| ₹1,154.40 | -23.60 | -2.0% | ₹1,178.00 | ₹1,178.10 | ₹1,154.40 | 2,001,757 | |
| ₹1,178.00 | +1.00 | +0.1% | ₹1,175.00 | ₹1,186.60 | ₹1,172.50 | 682,712 | |
| ₹1,177.00 | -5.00 | -0.4% | ₹1,182.00 | ₹1,191.90 | ₹1,169.40 | 1,044,405 | |
| ₹1,182.00 | -11.50 | -1.0% | ₹1,189.90 | ₹1,197.20 | ₹1,180.10 | 1,993,156 | |
| ₹1,193.50 | +3.50 | +0.3% | ₹1,189.00 | ₹1,193.50 | ₹1,175.00 | 1,569,853 | |
| ₹1,190.00 | +15.30 | +1.3% | ₹1,179.40 | ₹1,195.90 | ₹1,168.60 | 2,248,634 | |
| ₹1,174.70 | -5.30 | -0.4% | ₹1,179.00 | ₹1,185.10 | ₹1,174.00 | 1,246,756 | |
| ₹1,180.00 | +10.00 | +0.9% | ₹1,171.20 | ₹1,183.80 | ₹1,171.20 | 1,031,107 |
Splits
2 splits since 2006 · NSE:DRREDDY · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- NSE:DRREDDY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · Nov 5, 2026
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Dr. Reddy s receives marketing authorization for generic semaglutide injection in Brazil".
Latest earnings call · Oct 23, 2026
Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Oct 23, 2026
Q2 2027 Earnings Presentation
Earnings · 15 slides
Latest news
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Dr. Reddy s receives marketing authorization for generic semaglutide injection in Brazil".
Nov 4, 2026
Closed ₹1,366.00 (-0.6%) on Nov 5, 2026
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Dr. Reddy s Receives DCGI Approval for Zytorvi® (toripalimab) in Advanced Esophageal Squamous Cell Carcinoma, Its Second Approved Indication in India.".
Oct 21, 2026
Closed ₹1,244.50 (+0.2%) on Oct 21, 2026
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 07, 2026, titled "Intimation of Earnings call".
Oct 7, 2026
Closed ₹1,203.80 (-0.3%) on Oct 7, 2026
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
Aug 4, 2026
Closed ₹1,172.60 (-0.6%) on Aug 4, 2026
Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026
Aug 1, 2026
Closed ₹1,180.00 (+3.0%) on Aug 3, 2026
Dr. Reddy's Laboratories Ltd. Press Release Jul 23 2026
Jul 22, 2026
Closed ₹1,169.80 (-0.9%) on Jul 23, 2026
Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026
Jul 13, 2026
Closed ₹1,236.00 (-0.8%) on Jul 13, 2026
Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
Jun 29, 2026
Closed ₹1,361.00 (-1.4%) on Jun 30, 2026
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
Jun 13, 2026
Closed ₹1,279.00 (+0.5%) on Jun 15, 2026
Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F)
May 29, 2026
Closed ₹1,286.50 (-2.5%) on Jun 1, 2026
Dr. Reddy's Laboratories Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 31 in the last 12 months · 163 in all · newest Nov 5, 2026 · oldest 2020
- Calls
- 25 calls with a replay · 25 with a transcript · latest Oct 23, 2026
- Decks
- 95 decks · latest Oct 23, 2026
Where Dr. Reddy's Laboratories Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:DRREDDY · Home listing · This page | NSE | India | INR |
| NYSE:RDY | NYSE | United States | USD |
| BSE:DRREDDY | BSE | India | INR |
| gettex:RDDA | gettex | Germany | EUR |
| B3:R1DY34 | B3 | Brazil | BRL |
| BOATS:RDY | BOATS | United States | USD |
| Frankfurt:RDDA | Frankfurt | Germany | EUR |
| Lang & Schwarz:659157 | Lang & Schwarz | Germany | EUR |
| LS Exchange:659157 | LS Exchange | Germany | EUR |
| Stuttgart:RDDA | Stuttgart | Germany | EUR |
| Munich:RDDA | Munich | Germany | EUR |
| Dusseldorf:RDDA | Dusseldorf | Germany | EUR |
Valuation
P/E 41.4× against a median of 39.5×: 6th lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹1.15T INR
- P/E
- 41.4×
- EV/sales
- 3.5×
- EV/EBITDA
- 22.6×
- Price/book
- 3.0×
- Gross margin
- 49.5%
- Operating margin
- 9.0%
- Net margin
- 8.5%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. · NSE:DRREDDY | US$12.50B | US$12.46B | 41.4× | 3.5× | 22.6× | 3.0× | 8.5% | 0.2× | n/a |
| Yunnan Baiyao Group Co. Ltd. Class A · SZSE:000538 | US$15.10B | US$13.13B | 19.4× | 2.0× | n/a | 2.5× | 12.2% | 0.0× | n/a |
| Jazz Pharmaceuticals plc · NASDAQ:JAZZ | US$14.95B | US$18.48B | 72.6× | 3.9× | n/a | 3.6× | 4.4% | 1.3× | 0.64 |
| Ipsen SA · EURONEXT:IPN | US$14.62B | US$13.51B | 30.0× | 3.4× | 11.2× | 2.8× | 12.1% | 0.2× | n/a |
| Laurus Labs Ltd. · NSE:LAURUSLABS | US$13.38B | US$13.66B | 92.5× | 16.2× | 53.2× | 20.5× | 17.1% | 0.4× | n/a |
| Zydus Lifesciences Limited · NSE:ZYDUSLIFE | US$12.92B | US$13.86B | 28.6× | 4.2× | 17.9× | 4.3× | 13.8% | 0.5× | n/a |
| Elanco Animal Health Incorporated · NYSE:ELAN | US$12.87B | US$15.85B | n/a | 3.1× | 13.1× | 1.9× | −2.9% | 0.5× | 1.20 |
| Cipla Ltd · NSE:CIPLA | US$12.34B | US$11.27B | 39.5× | 3.7× | 21.6× | 3.2× | 10.4% | 0.0× | n/a |
| Mankind Pharma Ltd. · NSE:MANKIND | US$11.88B | US$12.18B | 49.1× | 7.3× | 27.7× | 6.3× | 14.6% | 0.3× | n/a |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A · SSE:600436 | US$11.64B | US$11.32B | 58.9× | 9.5× | n/a | 5.5× | 16.7% | 0.0× | n/a |
| Aurobindo Pharma Ltd · NSE:AUROPHARMA | US$11.17B | US$11.03B | 25.9× | 2.8× | 13.4× | 2.6× | 10.8% | 0.2× | n/a |
| Median of the others | US$12.89B | US$13.32B | 39.5× | 3.8× | 17.9× | 3.4× | 12.1% | 0.3× | 0.92 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1358.95 INR · Analysts' mean
- EPS, year to Mar 2027
- 44.28 · 32 analysts
- Revenue, year to Mar 2027
- 351.3B · 34 analysts
Team and board
| Officer | Role |
|---|---|
| Deepak Sapra | CEO API & Services |
| Murali Ramachandra | Chief Executive Officer |
| Aishwarya Sitharam | INVESTOR RELATIONS |
Events
- Next results
- Jan 21, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call | Fri, Oct 23, 2026 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call | Wed, Jul 22, 2026 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 2026 Earnings Call | Tue, May 12, 2026 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 2026 Earnings Call | Wed, Jan 21, 2026 · 7:30 PM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2026 Earnings Call | Fri, Oct 24, 2025 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2026 Earnings Call | Wed, Jul 23, 2025 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 2025 Earnings Call | Fri, May 09, 2025 · 10:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 2025 Earnings Call | Thu, Jan 23, 2025 · 9:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2025 Earnings Call | Tue, Nov 05, 2024 · 9:00 AM ET | Replay |
| Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 2024 Earnings Call | Tue, May 07, 2024 · 10:00 AM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Oct 23, 2026 · Before open | −0.8% |
| Q1 2027 | Jul 22, 2026 · Before open | −2.2% |
| Q4 2026 | May 12, 2026 · Before open | −1.1% |
| Q3 2026 | Jan 21, 2026 · Before open | −1.4% |
| Q2 2026 | Oct 24, 2025 · Before open | +0.2% |
| Q1 2026 | Jul 23, 2025 · Before open | +0.7% |
| Q4 2025 | May 9, 2025 · Before open | +1.1% |
| Q3 2025 | Jan 23, 2025 · Before open | −0.5% |
| Q2 2025 | Nov 5, 2024 · Before open | +0.6% |
| Q1 2025 | Jul 27, 2024 · Before open | −1.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 7, 2024 · Before open | −0.7% |
| Q3 2024 | Jan 30, 2024 · Before open | −0.8% |
| Q2 2024 | Oct 27, 2023 · Before open | −0.1% |
| Q1 2024 | Jul 26, 2023 · After close | +0.7% |
| Q4 2023 | May 10, 2023 · Before open | −1.1% |
| Q3 2023 | Jan 25, 2023 · Before open | −1.1% |
| Q2 2023 | Oct 28, 2022 · After close | −0.4% |
| Q1 2023 | Jul 28, 2022 · After close | −3.9% |
| Q4 2022 | May 18, 2022 | +0.6% |
| Q3 2022 | Jan 28, 2022 · Before open | −0.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2027 Earnings Presentation | Earnings | 15 slides | Oct 23, 2026 |
| Q2 FY27 Earnings Presentation | Earnings | 17 slides | Oct 23, 2026 |
| Q2 FY27 Earnings Presentation | Earnings | 17 slides | Oct 23, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 16 slides | Jul 22, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 16 slides | Jul 22, 2026 |
| Q4 FY2026 Earnings Presentation | Earnings | 18 slides | May 12, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 17 slides | May 12, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 18 slides | Jan 21, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 17 slides | Jan 21, 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 18 slides | Oct 24, 2025 |
Show 50 decks
This page holds 50 of 95 decks. Open Decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 335.9B | 325.5B | 279.2B | 245.9B | 214.4B | 189.7B | 174.6B | 153.9B | 141.9B | 139.9B |
| Cost of revenue | 158.7B | 135.1B | 115.6B | 106.5B | 100.6B | 86.6B | 80.6B | 70.4B | 65.6B | 61.5B |
| Gross profit | 177.3B | 190.4B | 163.6B | 139.3B | 113.8B | 103.1B | 94.0B | 83.4B | 76.3B | 78.4B |
| Research and development | 24.1B | 27.4B | 22.9B | 19.4B | 17.5B | 16.5B | 15.4B | 15.6B | 18.3B | 19.6B |
| Selling, general and administrative | 59.9B | 93.9B | 77.2B | 46.5B | 46.5B | 54.6B | 58.8B | 58.4B | 56.7B | 56.1B |
| Operating income | 46.4B | 71.8B | 67.7B | 57.1B | 29.5B | 24.3B | 16.0B | 20.9B | 11.9B | 13.5B |
| Depreciation and amortization | 20.6B | 17.1B | 14.8B | 12.5B | 11.8B | 12.8B | 12.5B | 12.2B | 11.7B | 11.3B |
| EBITDA | 67.0B | 88.9B | 82.6B | 69.6B | 41.3B | 37.1B | 28.5B | 33.1B | 23.6B | 24.8B |
| Interest expense | 3.74B | 2.83B | 1.71B | 1.43B | 958.0M | 970.0M | 983.0M | 889.0M | 788.0M | 634.0M |
| Income before tax | 54.8B | 76.8B | 71.9B | 60.4B | 32.3B | 26.4B | 18.0B | 22.4B | 14.3B | 14.7B |
| Income tax | 12.4B | 19.5B | 16.2B | 15.3B | 8.73B | 9.18B | -1.47B | 3.65B | 4.54B | 2.61B |
| Net income | 42.9B | 56.5B | 55.7B | 45.1B | 23.6B | 17.2B | 19.5B | 18.8B | 9.81B | 12.0B |
| Earnings per share, basic | 51.42 | 67.78 | 66.80 | 54.17 | 28.34 | 20.73 | 23.48 | 22.62 | 11.80 | 14.42 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.4B | 14.7B | 7.11B | 5.78B | 14.9B | 14.8B | 2.05B | 2.23B | 2.64B | 18.1B |
| Short-term investments | 72.4B | 43.3B | 74.4B | 56.0B | 29.5B | 19.7B | 23.7B | 22.5B | 18.3B | 14.3B |
| Receivables | 123.2B | 90.4B | 80.3B | 85.9B | 80.3B | 61.7B | 61.8B | 45.6B | 54.8B | 49.1B |
| Inventory | 76.5B | 71.1B | 63.6B | 48.7B | 50.9B | 45.4B | 35.1B | 33.6B | 29.1B | 28.5B |
| Current assets | 302.0B | 250.1B | 248.0B | 204.3B | 181.1B | 148.2B | 130.4B | 114.5B | 109.6B | 100.4B |
| Property, plant and equipment | 97.0B | 76.0B | 66.3B | 62.2B | 57.1B | 52.3B | 54.1B | 57.9B | 57.2B | |
| Goodwill | 12.9B | 11.8B | 4.25B | 5.47B | 4.42B | 4.57B | 3.99B | 3.90B | 3.94B | 3.75B |
| Total assets | 579.3B | 493.0B | 387.5B | 322.9B | 296.7B | 265.5B | 232.2B | 225.4B | 225.6B | 219.8B |
| Accounts payable | 33.4B | 20.1B | 21.5B | 17.9B | 16.0B | 12.7B | 10.7B | 10.3B | 9.21B | 13.4B |
| Current liabilities | 167.6B | 130.4B | 96.0B | 85.7B | 94.0B | 83.4B | 72.8B | 59.7B | 69.7B | 85.0B |
| Long-term debt | 12.2B | 3.80B | 3.80B | 0 | 5.75B | 6.30B | 0 | 21.4B | 24.5B | 4.85B |
| Total debt | 89.5B | 46.8B | 20.0B | 13.5B | 33.8B | 30.3B | 22.1B | 38.4B | 50.7B | 49.2B |
| Total liabilities | 198.9B | 155.8B | 107.0B | 90.0B | 106.1B | 90.5B | 77.3B | 85.2B | 99.1B | 95.8B |
| Shareholders' equity | 377.1B | 333.4B | 280.6B | 231.0B | 190.5B | 173.1B | 155.0B | 140.2B | 126.5B | 124.0B |
| Shares outstanding | 833.3M | 834.2M | 833.5M | 831.9M | 831.7M | 831.6M | 830.4M | 831.0M | 830.9M | 835.0M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 53.8B | 46.4B | 45.4B | 58.9B | 28.1B | 35.7B | 29.8B | 28.7B | 18.0B | 21.5B |
| Capital spending | -23.3B | -27.5B | -27.4B | -18.9B | -19.0B | -12.6B | -6.12B | -7.49B | -11.0B | -41.0B |
| Free cash flow | 30.5B | 18.9B | 18.0B | 40.0B | 9.06B | 23.1B | 23.7B | 21.2B | 6.99B | -19.5B |
| Cash from investing | -67.0B | -51.0B | -40.3B | -41.4B | -26.4B | -22.7B | -4.92B | -7.73B | -14.9B | -18.5B |
| Cash from financing | 12.7B | 11.9B | -3.76B | -26.9B | -2.42B | -298.0M | -25.2B | -21.3B | -4.44B | -3.69B |
| Dividends paid | -6.66B | -6.66B | -6.65B | -4.98B | -4.15B | -4.15B | -3.92B | -4.00B | -3.99B | -3.39B |
| Share buybacks | 0 | -1.39B | 805.0M | 647.0M | 451.0M | -1.19B | -474.0M | -535.0M | 1.00M | -15.7B |
| Change in cash | 714.0M | 7.49B | 1.33B | -9.07B | 32.0M | 12.9B | -266.0M | -314.0M | -1.24B | -1.14B |
Filings
All 133 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Mar 21 2026 | Mar 21, 2026 | Other filings | NSE India |
| Press Release Feb 18 2026 | Feb 18, 2026 | Acquisition or disposal | NSE India |
| Press Release Jan 14 2026 | Jan 14, 2026 | Operations update | NSE India |
| Press Release Jan 08 2026 | Jan 8, 2026 | Results | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Dec 12 2025 | Dec 11, 2025 | Other filings | NSE India |
| Press Release Nov 24 2025 | Nov 24, 2025 | Operations update | NSE India |
| Press Release Oct 13 2025 | Oct 13, 2025 | Results | NSE India |
| Press Release Sep 16 2025 | Sep 16, 2025 | Operations update | NSE India |
| Press Release Jul 23 2025 | Jul 23, 2025 | Other filings | NSE India |
| Press Release Jul 15 2025 | Jul 15, 2025 | Results | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Jun 05 2025 | Jun 4, 2025 | Other filings | NSE India |
| Press Release Apr 24 2025 | Apr 24, 2025 | Results | NSE India |
| Press Release Mar 13 2025 | Mar 13, 2025 | Other filings | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Nov 28 2024 | Nov 27, 2024 | Operations update | NSE India |
| Press Release Oct 28 2024 | Oct 28, 2024 | Operations update | NSE India |
| Press Release Oct 08 2024 | Oct 8, 2024 | Other filings | NSE India |
| Press Release Oct 02 2024 | Oct 2, 2024 | Other filings | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Jul 29 2024 | Jul 28, 2024 | Other filings | NSE India |
| Press Release Jul 18 2024 | Jul 18, 2024 | Other filings | NSE India |
| Press Release Jun 28 2024 | Jun 28, 2024 | Other filings | NSE India |
| Press Release Jun 03 2024 | Jun 3, 2024 | Other filings | NSE India |
| Press Release May 07 2024 | May 7, 2024 | Other filings | NSE India |
| Press Release Jan 30 2024 | Jan 30, 2024 | Results | NSE India |
| Press Release Jan 03 2024 | Jan 3, 2024 | Other filings | NSE India |
| Press Release Dec 14 2023 | Dec 14, 2023 | Other filings | NSE India |
| Press Release Dec 06 2023 | Dec 6, 2023 | Other filings | NSE India |
| Press Release Nov 16 2023 | Nov 16, 2023 | Operations update | NSE India |
| Press Release Oct 27 2023 | Oct 27, 2023 | Results | NSE India |
| Press Release Aug 10 2023 | Aug 10, 2023 | Other filings | NSE India |
| Press Release Jul 26 2023 | Jul 26, 2023 | Quarterly report | NSE India |
| Press Release Jul 12 2023 | Jul 12, 2023 | Other filings | NSE India |
| Press Release Jun 23 2023 | Jun 23, 2023 | Other filings | NSE India |
| Press Release Jun 14 2023 | Jun 14, 2023 | Other filings | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Jun 05 2023 | Jun 4, 2023 | Operations update | NSE India |
| Press Release May 10 2023 | May 10, 2023 | Results | NSE India |
| Press Release May 05 2023 | May 5, 2023 | Other filings | NSE India |
| Press Release Apr 21 2023 | Apr 21, 2023 | Other filings | NSE India |
| Press Release Mar 16 2023 | Mar 16, 2023 | Other filings | NSE India |
| Dr. Reddy's Laboratories Ltd. Press Release Feb 27 2023 | Feb 26, 2023 | Acquisition or disposal | NSE India |
| Press Release Feb 08 2023 | Feb 8, 2023 | Other filings | NSE India |
| Press Release Jan 27 2023 | Jan 27, 2023 | Other filings | NSE India |
| Press Release Jan 20 2023 | Jan 20, 2023 | Other filings | NSE India |
| Press Release Jan 13 2023 | Jan 13, 2023 | Other filings | NSE India |
| Press Release Dec 19 2022 | Dec 19, 2022 | Other filings | NSE India |
| Press Release Dec 16 2022 | Dec 16, 2022 | Other filings | NSE India |
| Press Release Oct 11 2022 | Oct 11, 2022 | Other filings | NSE India |
| Press Release Sep 07 2022 | Sep 7, 2022 | Other filings | NSE India |
| Press Release Jul 27 2022 | Jul 27, 2022 | Other filings | NSE India |
| Press Release Jul 22 2022 | Jul 22, 2022 | Other filings | NSE India |
| Press Release Jul 08 2022 | Jul 8, 2022 | Other filings | NSE India |
| Press Release Jun 28 2022 | Jun 28, 2022 | Other filings | NSE India |
| Press Release Jun 24 2022 | Jun 24, 2022 | Other filings | NSE India |
| Press Release Jun 14 2022 | Jun 14, 2022 | Operations update | NSE India |
| Press Release Jun 09 2022 | Jun 9, 2022 | Other filings | NSE India |
| Press Release May 27 2022 | May 27, 2022 | Other filings | NSE India |
| Press Release May 24 2022 | May 24, 2022 | Operations update | NSE India |
| Press Release May 11 2022 | May 11, 2022 | Other filings | NSE India |
| Press Release Apr 20 2022 | Apr 20, 2022 | Operations update | NSE India |
| Press Release Apr 05 2022 | Apr 5, 2022 | Operations update | NSE India |
| Press Release Feb 21 2022 | Feb 21, 2022 | Other filings | NSE India |
| Press Release Feb 11 2022 | Feb 11, 2022 | Other filings | NSE India |
| Press Release Feb 09 2022 | Feb 9, 2022 | Other filings | NSE India |
| Press Release Feb 07 2022 | Feb 7, 2022 | Other filings | NSE India |
| Press Release Feb 03 2022 | Feb 3, 2022 | Other filings | NSE India |
| Press Release Feb 02 2022 | Feb 2, 2022 | Other filings | NSE India |
| Press Release Jan 17 2022 | Jan 17, 2022 | Other filings | NSE India |
| Press Release Dec 28 2021 | Dec 28, 2021 | Other filings | NSE India |
| Press Release Dec 09 2021 | Dec 9, 2021 | Other filings | NSE India |
| Press Release Oct 29 2021 | Oct 29, 2021 | Other filings | NSE India |
| Press Release Oct 19 2021 | Oct 19, 2021 | Other filings | NSE India |
| Press Release Oct 15 2021 | Oct 15, 2021 | Other filings | NSE India |
| Press Release Oct 14 2021 | Oct 14, 2021 | Other filings | NSE India |
| Press Release Oct 07 2021 | Oct 7, 2021 | Other filings | NSE India |
| Press Release Sep 07 2021 | Sep 7, 2021 | Other filings | NSE India |
| Press Release Sep 04 2021 | Sep 4, 2021 | Other filings | NSE India |
| Press Release Sep 02 2021 | Sep 2, 2021 | Operations update | NSE India |
| Press Release Aug 31 2021 | Aug 31, 2021 | Other filings | NSE India |
| Press Release Aug 04 2021 | Aug 4, 2021 | Other filings | NSE India |
| Press Release Aug 03 2021 | Aug 3, 2021 | Operations update | NSE India |
| Press Release Jul 27 2021 | Jul 27, 2021 | Operations update | NSE India |
| Press Release Jul 07 2021 | Jul 7, 2021 | Results | NSE India |
| Press Release Jun 30 2021 | Jun 30, 2021 | Other filings | NSE India |
| Press Release Jun 29 2021 | Jun 29, 2021 | Other filings | NSE India |
| Press Release Jun 28 2021 | Jun 28, 2021 | Other filings | NSE India |
| Press Release Jun 22 2021 | Jun 22, 2021 | Other filings | NSE India |
| Press Release May 14 2021 | May 14, 2021 | Operations update | NSE India |
| Press Release May 12 2021 | May 12, 2021 | Other filings | NSE India |
| Press Release May 11 2021 | May 11, 2021 | Other filings | NSE India |
| Press Release Apr 29 2021 | Apr 29, 2021 | Other filings | NSE India |
| Press Release Apr 23 2021 | Apr 23, 2021 | Other filings | NSE India |
| Press Release Apr 13 2021 | Apr 13, 2021 | Other filings | NSE India |
| Press Release Apr 07 2021 | Apr 7, 2021 | Other filings | NSE India |
| Press Release Feb 22 2021 | Feb 22, 2021 | Other filings | NSE India |
| Press Release Feb 19 2021 | Feb 19, 2021 | Other filings | NSE India |
| Press Release Feb 18 2021 | Feb 18, 2021 | Other filings | NSE India |
| Press Release Feb 17 2021 | Feb 17, 2021 | Other filings | NSE India |
| Press Release Feb 02 2021 | Feb 2, 2021 | Other filings | NSE India |
| Press Release Jan 27 2021 | Jan 27, 2021 | Other filings | NSE India |
| Press Release Jan 15 2021 | Jan 15, 2021 | Other filings | NSE India |
| Press Release Jan 11 2021 | Jan 11, 2021 | Other filings | NSE India |
| Press Release Jan 08 2021 | Jan 8, 2021 | Other filings | NSE India |
| Press Release Dec 09 2020 | Dec 9, 2020 | Other filings | NSE India |
| Press Release Dec 01 2020 | Dec 1, 2020 | Other filings | NSE India |
| Press Release Nov 28 2020 | Nov 28, 2020 | Other filings | NSE India |
| Press Release Nov 12 2020 | Nov 12, 2020 | Other filings | NSE India |
| Press Release Oct 29 2020 | Oct 29, 2020 | Other filings | NSE India |
| Press Release Oct 28 2020 | Oct 28, 2020 | Other filings | NSE India |
| Press Release Oct 20 2020 | Oct 20, 2020 | Other filings | NSE India |
| Press Release Oct 17 2020 | Oct 17, 2020 | Other filings | NSE India |
| Press Release Oct 12 2020 | Oct 12, 2020 | Other filings | NSE India |
| Press Release Oct 05 2020 | Oct 5, 2020 | Other filings | NSE India |
| Press Release Oct 03 2020 | Oct 3, 2020 | Other filings | NSE India |
| Press Release Oct 01 2020 | Oct 1, 2020 | Other filings | NSE India |
| Press Release Sep 26 2020 | Sep 26, 2020 | Other filings | NSE India |
| Press Release Sep 25 2020 | Sep 25, 2020 | Other filings | NSE India |
| Press Release Sep 17 2020 | Sep 17, 2020 | Other filings | NSE India |
| Press Release Sep 16 2020 | Sep 16, 2020 | Other filings | NSE India |
| Press Release Sep 09 2020 | Sep 9, 2020 | Other filings | NSE India |
| Press Release Sep 07 2020 | Sep 7, 2020 | Other filings | NSE India |
| Press Release Sep 03 2020 | Sep 3, 2020 | Other filings | NSE India |
| Press Release Aug 27 2020 | Aug 27, 2020 | Other filings | NSE India |
| Press Release Aug 19 2020 | Aug 19, 2020 | Other filings | NSE India |
| Press Release Aug 11 2020 | Aug 11, 2020 | Other filings | NSE India |
Cap table
Built by 6ix from Dr. Reddy's Laboratories Ltd.’s releases
- Common shares
- 833,072,850
- Fully diluted
- 833,072,850
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 833,072,850 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 833,072,850 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aishwarya Sitharam | INVESTOR RELATIONS · Since at least Aug 4, 2026 |
| Murali Ramachandra | Chief Executive Officer · Since at least Dec 2, 2025 |
Log in to ask 6ix AI your own questions about Dr. Reddy's Laboratories Ltd.